The Neuropathology of Huntington's Disease: Classical Findings, Recent Developments and Correlation to Functional Neuroanatomy

The Neuropathology of Huntington's Disease: Classical Findings, Recent Developments and Correlation to Functional Neuroanatomy

Volumn 217, Issue , 2015, Pages 1-146

  Rüb, Udo ^a   Vonsattel, Jean Paul G ^b   Heinsen, Helmut ^c,d   Korf, Horst Werner ^a  

^a GOETHE UNIVERSITY   (Germany)

^b NEUROLOGICAL INSTITUTE   (United States)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

HTT PROTEIN, HUMAN; NERVE PROTEIN;

BRAIN; GENETICS; HISTORY; HUMAN; HUNTINGTON DISEASE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

BRAIN; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; HUNTINGTON DISEASE; NERVE TISSUE PROTEINS;

EID: 84952633601     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-319-19285-7     Document Type: Book

References (300)

1. Alzheimer A (1911) Über die anatomische Grundlage der Huntington'schen Chorea und der choreatischen Bewegung überhaupt. Neurol Centralblatt 30:891-892
2. Andrew SE, Goldberg YP, Kremer B, Telenius H, Theilmann J, Adam S, Starr A, Squitieri S, Lin B, Kalchman MA, Graham RK, Hayden MR (1993) The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease. Nat Genet 4:398-403
3. Armstrong E (1990) Evolution of the brain. In: Paxinos G (ed) The human nervous system. Academic Press, San Diego, pp 1-16
4. Arzberger T, KrampflK, Leimgruber S, Weindl A (1997) Changes of NMDA receptor subunit (NR1, NR2b) and glutamate transporter (GLT1) mRNA expression in Huntington's disease: an in situ hybridization study. J Neuropathol Exp Neurol 56:440-454
5. Atkin G, Paulson H (2014) Ubiquitin pathways in neurodegenerative disease. Front Mol Neurosci 7:63
6. Avanzini G, Girotti F, Caraceni T, Spreafico R (1979) Oculomotor disorders in Huntington's chorea. J Neurol Neurosurg Psychiatry 42:581-589
7. Aylward EH, Nopoulos PC, Ross CA, Langbehn DR, Pierson RK, Mills JA, Johnson HJ, Magnotta VA, Juhl AR, Paulsen J, PREDICT-HD investigators and Coordinators of Huntington Study Group (2011) Longitudinal change in regional brain volumes in prodromal Huntington disease. J Neurol Neurosurg Psychiatry 82:405-410
8. Aziz NA, van der Marck MA, Pijl H, Olde Rikkert MG, Bloem BR, Roos RA (2008) Weight loss in neurodegenerative disorders. J Neurol 255:1872-1880
9. Barbas H, Henion THH, Dermon CR (1991) Diverse thalamic projections to the prefrontal cortex in the rhesus monkey. J Comp Neurol 313:65-94
10. Bartzokis G, Lu PH, Tishler TA, Fong SM, Oluwadara B, Finn JP, Huang D, Bordelon Y, Mintz J, Perlman S (2007) Myelin breakdown and iron changes in Huntington's disease: pathogenesis and treatment implications. Neurochem Res 32:1655-1664
11. Bastianelli E (2003) Distribution of calcium-binding proteins in the cerebellum. Cerebellum 2:242-262
12. Becher MW, Kotzuk JA, Sharp AH, Davies SW, Bates GP, Price DL, Ross CA (1998) Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: correlation between the density of inclusions and IT15 CAG triplet repeat length. Neurobiol Dis 4:387-397
13. Beenen N, Büttner U, Lange HW (1986) The diagnostic value of eye movement recordings in patients with Huntington's disease and their offspring. Electroencephalogr Clin Neurophysiol 63:119-127
14. Benninghoff A, Drenckhahn D (eds) (2004) Anatomie: Makroskopische Anatomie, Histologie, Embryologie, Zellbiologie, vol 2, 16th edn. Elsevier GmbH, Urban & Fische, Munich
15. Bhatia KP, Marsden CD (1994) The behavioural and motor consequences of focal lesions of the basal ganglia in man. Brain 117:859-876
16. Birnbaum G (1941) Chronisch-progressive Chorea mit Kleinhirnatrophie. Arch Psychiatr Nervenk 114:160-182
17. Blekher TM, Yee RD, Kirkwood SC, Hake AM, Stout JC, Weaver MR, Foroud TM (2004) Oculomotor control in asymptomatic and recently diagnosed individuals with the genetic marker for Huntington's disease. Vision Res 44:2729-2736
18. Blekher T, Johnson SA, Marshall J, White K, Hui S, Weaver M, Gray J, Yee R, Stout JC, Beristain X, Wojcieszek J, Foroud T (2006) Saccades in presymptomatic and early stages of Huntington disease. Neurology 67:394-399
19. Bollen E, Reulen JP, den Heyer JC, van der Kamp W, Roos RA, Buruma OJ (1986) Horizontal and vertical saccadic eye movement abnormalities in Huntington's chorea. J Neurol Sci 74: 11-22
20. Borrell-Pagès M, Zala D, Humbert S, Saudou F (2006) Huntington's disease: from huntingtin function and dysfunction to therapeutic strategies. Cell Mol Life Sci 63:2642-2660
21. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239-259
22. Braak H, Braak E (1992a) The human entorhinal cortex: normal morphology and lamina-specific pathology in various diseases. Neurosci Res 15:6-31
23. Braak H, Braak E (1992b) Allocortical involvement in Huntington's disease. Neuropathol Appl Neurobiol 18:539-547
24. Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E (2003a) Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24:197-211
25. Braak H, Rüb U, Del Tredici K (2003b) Involvement of precerebellar nuclei in multiple system atrophy. Neuropathol Appl Neurobiol 29:60-76
26. Braak H, Rüb U, Gai WP, Del Tredici K (2003c) Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm 110:517-536
27. Braak H, Ghebremedhin E, Rüb U, Bratzke H, Del Tredici K (2004) Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res 318:121-134
28. Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112:389-404
29. Brandt J, Folstein SE, Folstein MF (1988) Differential cognitive impairment in Alzheimer's disease and Huntington's disease. Ann Neurol 23:555-556
30. Brodmann K (1909) Vergleichende Lokalisationslehre der Großhirnrinde. Johann Ambrosius Barth, Leipzig
31. Brundin P, Melki R, Kopito R (2010) Prion-like transmission of protein aggregates in neurodegenerative diseases. Nat Rev Mol Cell Biol 11:301-307
32. Bruyn GW (1968) Huntington's chorea. Historical, clinical and laboratory synopsis. In: Vinken PJ, Bruyn GW (eds) Handbook of clinical neurology, vol 6, Diseases of the basal ganglia. North-Holland, Amsterdam, pp 298-378
33. Bruyn GW, Bots GTAM, Dom R (1979) Huntington's chorea: current neuropathological status. Adv Neurol 23:83-93
34. Busse ME, Wiles CM, Rosser AE (2009) Mobility and falls in people with Huntington's disease. J Neurol Neurosurg Psychiatry 80:88-90
35. Butters N, Albert MS, Sax D (1979) Investigations of the memory disorders of patients with Huntington's disease. Adv Neurol 23:203-213
36. Büttner U, Büttner-Ennever JA (2006) Present concepts of oculomotor organization. Prog Brain Res 151:1-42
37. Büttner-Ennever JA (2006) The extraocular motor nuclei: organization and functional neuroanatomy. Prog Brain Res 151:95-125
38. Büttner-Ennever JA, Gerrits NM (2004) Vestibular system. In: Paxinos G, Mai JK (eds) The human nervous system, 2nd edn. Elsevier, San Diego, pp 1213-1240
39. Büttner-Ennever JA, Horn AKE (1997) Anatomical substrates of oculomotor control. Curr Opin Neurobiol 7:872-879
40. Büttner-Ennever JA, Horn AKE (2004) Reticular formation: eye movements, gaze, and blinks. In: Paxinos G, Mai JK (eds) The human nervous system, 2nd edn. Elsevier, San Diego, pp 479-510
41. Büttner-Ennever JA, Büttner U, Cohen B, Baumgartner G (1982) Vertical glaze paralysis and the rostral interstitial nucleus of the medial longitudinal fasciculus. Brain 105:125-149
42. Büttner-Ennever JA, Cohen B, Pause M, Fries W (1988) Raphe nucleus of the pons containing omnipause neurons of the oculomotor system in the monkey, and its homologue in man. J Comp Neurol 267:307-321
43. Campbell AM, Corner B, Norman RM, Urich H (1961) The rigid form of Huntington's disease. J Neurol Neurosurg Psychiatry 24:71-77
44. Carmichael ST, Price JL (1996) Connectional networks within the orbital and medial prefrontal cortex of macaque monkeys. J Comp Neurol 371:179-207
45. Cattaneo E, Zuccato C, Tartari M (2005) Normal huntingtin function: an alternative approach to Huntington's disease. Nat Rev Neurosci 6:919-939
46. Coggeshall RE, Lekan HA (1996) Methods for determining numbers of cells and synapses: a case for more uniform standards of review. J Comp Neurol 364:6-15
47. Collewijn H, Went LN, Tamminga EP, Vegter-Van der Vlis M (1988) Oculomotor defects in patients with Huntington's disease and their offspring. J Neurol Sci 86:307-320
48. Costanzo M, Zurzolo C (2013) The cell biology of prion-like spread of protein aggregates: mechanisms and implication in neurodegeneration. Biochem J 452:1-17
49. Cudkowicz M, Kowall NW (1990) Degeneration of pyramidal projection neurons in Huntington's disease cortex. Ann Neurol 27:200-204
50. Davies JE, Sarkar S, Rubinsztein DC (2007) The ubiquitin proteasome system in Huntington's disease and the spinocerebellar ataxias. BMC Biochem 8(Suppl):1-8
51. Davison C, Goodhart SP, Shlionsky H (1932) Chronic progressive chorea. The pathogenesis and mechanism; a histopathologic study. Arch Neurol Psychiat 27:906-928
52. De la Monte SM, Vonsattel JP, Richardson EP Jr (1988) Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington's disease. J Neuropathol Exp Neurol 47:516-525
53. De Vos KJ, Grierson AJ, Ackerley S, Miller CCJ (2008) Role of axonal transport in neurodegenerative diseases. Annu Rev Neurosci 31:1151-1173
54. Den Dunnen WF (2013) Neuropathological diagnostic considerations in hyperkinetic movement disorders. Front Neurol 4:7
55. Deuschl G, Lücking CH, Schenck E (1989) Hand muscle reflexes following electrical stimulation in choreatic movement disorders. J Neurol Neurosurg Psychiatr 52:755-762
56. Dickson DW (1999) Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration. J Neurol 246(Suppl 2):6-15
57. Difiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel JP, Aronin N (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277:1990-1993
58. DiProspero NA, Chen EY, Charles V, Plomann M, Kordower JH, Tagle DA (2004) Early changes in Huntington's disease patient brains involve alterations in cytoskeletal and synaptic elements. J Neurocytol 33:517-533
59. Dom R, Malfroid M, Baro F (1976) Neuropathology of Huntington's chorea. Studies of the ventrobasal complex of the thalamus. Neurology 26:64-68
60. Dunlap CB (1927) Pathologic changes in Huntington's chorea: with special reference to the corpus striatum. Arch Neurol Psychiatry 18:867-943
61. Dunlop DS, Mc Hale DM, Lajtha A (1992) Decreased brain N-acetylaspartate in Huntington's disease. Brain Res 580:44-48
62. Duyao M, Ambrose C, Myers R, Novelletto A, Persichetti F, Frontali M, Folstein S, Ross C, Franz M, Abbott M, Gray J, Coneally P, Young A, Penney J, Hollingsworth Z, Shoulson I, Lazzarini A, Falck A, Koroshetz W, Sax D, Bird E, Vonsattel J, Bonilla E, Alvir J, Bickham Conde J, Cha JH, Dure L, Gomez F, Ramos M, Sanchez-Ramos J, Snodgrass S, de Young M, Wexler N, Moscowitz C, Penchaszadeh G, MacFarlane H, Anderson M, Jenkins B, Srinidhi J, Barnes G, Gusella JMM (1993) Trinucleotide repeat length instability and age of onset in Huntington's disease. Nat Genet 4:387-392
63. Duyckaerts C, Delatour B, Potier MC (2009) Classification and basic pathology of Alzheimer disease. Acta Neuropathol 118:5-36
64. Ellenberger C Jr, Petro DJ, Ziegler SB (1978) The visually evoked potential in Huntington disease. Neurology 28:95-97
65. Eng LF, Ghirnikar RS (1994) GFAP and astrogliosis. Brain Pathol 4:229-237
66. Eng LF, Ghirnikar RS, Lee YL (2000) Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000). Neurochem Res 25:1439-1445
67. Estrada-Sanchez AM, Rebec GV (2013) Role of cerebral cortex in the neuropathology of Huntington's disease. Front Neural Circuits 7:19
68. Fenelon G, Francois C, Percheron G, Yelnik J (1991) Topographic distribution of the neurons of the central complex (centre median-parafascicular complex) and of other thalamic neurons projecting to the striatum in macaques. Neuroscience 45:495-510
69. Fennema-Notestine C, Archibald SL, Jacobson MW, Corey-Bloom J, Paulsen JS, Peavy GM, Gamst AC, Hamilton JM, Salmon DR, Jernigan TL (2004) In vivo evidence of cerebellar atrophy and cerebral white matter loss in Huntington disease. Neurology 63:989-995
70. Ferrante RJ, Kowall NW, Beal MF, Martin JB, Bird ED, Richardson EPJ (1987) Morphologic and histochemical characteristics of a spared subset of striatal neurons in Huntington's disease. J Neuropathol Exp Neurol 46:12-27
71. Fielding J, Georgiou-Karistianis N, Bradshaw J, Millist L, Churchyard A, Chiu E, White O (2004) Impaired modulation of the vestibulo-ocular reflex in Huntington's disease. Mov Disord 19:68-75
72. Finkbeiner S, Mitra S (2008) The ubiquitin-proteasome pathway in Huntington's disease. ScientificWorldJournal 8:421-433
73. Forno LS, Jose C (1973) Huntington's chorea: a pathological study. In: Barbeau A, Chase TN, Paulson GW (eds) Huntington's chorea 1872-1972, vol 1, Huntington's chorea. Raven Press, New York, pp 453-470
74. François C, Percheron G, Parent A, Sadikot AF, Fenelon G, Yelnik J (1991) Topography of the projection from the central complex of the thalamus to the sensorimotor striatal territory in monkeys. J Comp Neurol 305:17-34
75. Freeman W, Watts JW (1947) Retrograde degeneration of the thalamus following prefrontal lobotomy. J Comp Neurol 86:65-93
76. Fujino Y, DeLucia MW, Davies P, Dickson DW (2004) Ballooned neurons in the limbic lobe are associated with Alzheimer type pathology and lack diagnostic specificity. Neuropathol Appl Neurobiol 30:676-682
77. Furtado S, Suchowersky O, Rewcastle B, Graham L, Klimek ML, Garber A (1996) Relationship between trinucleotide repeats and neuropathological changes in Huntington's disease. Ann Neurol 39:132-136
78. Fuster JM (1989) The prefrontal cortex. Raven Press, New York
79. Garey LJ (1990) Visual system. In: Paxinos G (ed) The human nervous system. Academic Press, San Diego, pp 945-977
80. Ghez C (1991) The cerebellum. In: Kandel ER, Schwartz JH, Jessell TM (eds) Principles of neural science, 3rd edn. Elsevier, New York, pp 596-607
81. Giguere M, Goldman-Rakic PS (1988) Mediodorsal nucleus: areal, laminar, and tangential distribution of afferents and efferents in the frontal lobe of rhesus monkeys. J Comp Neurol 277:195-213
82. Gil JM, Rego AC (2008) Mechanisms of neurodegeneration in Huntington's disease. Eur J Neurosci 27:2803-2820
83. Gilman S (1992) Cerebellum and motor dysfunction. In: Asbury AK, McKhann GM, McDonald WI (eds) Diseases of the nervous system: clinical neurobiology, 2nd edn. Saunders, Philadelphia, pp 368-389
84. Goedert M, Jakes R, Crowther RA, Cohen P, Vanmechelen E, Vandermeeren M, Cras P (1994) Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: identification of phosphorylation sites in tau protein. Biochem J 301:871-877
85. Goedert M, Clavaguera F, Tolnay M (2010) The propagation of prion-like protein inclusions in neurodegenerative diseases. Trend Neurosci 33:317-325
86. Golding CV, Danchaivijtr C, Hodgson TL, Trabizi SJ, Kennart C (2006) Identification of an oculomotor biomarker of preclinical Huntington disease. Neurology 67:485-487
87. Gómez-Tortosa E, Macdonald ME, Friend JC, Taylor SAM, Weiler LJ, Cupples LA, Srinidhi J, Gusella JF, Bird ED, Vonsattel JP, Myers RH (2001) Quantitative neuropathological changes in presymptomatic Huntington's disease. Ann Neurol 49:29-34
88. Gourfinkel-An I, Cancel G, Duyckaerts C, Faucheux B, Hauw JJ, Trottier Y, Brice A, Agid Y, Hirsch EC (1998) Neuronal distribution of intranuclear inclusions in Huntington's disease with adult onset. Neuroreport 9:1823-1826
89. Graeber MB, Moran LB (2002) Mechanisms of cell death in neurodegenerative diseases: fashion, fiction, and facts. Brain Pathol 12:385-390
90. Grimbergen YA, Knol MJ, Bloem BR, Kremer BP, Roos RA, Munneke M (2008) Falls and gait disturbances in Huntington's disease. Mov Disord 23:970-976
91. Grinberg LT, Heinsen H (2009) Argyrophilic grain disease. An update on a frequent cause of dementia. Dement Neuropsych 3:2-7
92. Groenewegen HJ (2003) The basal ganglia and motor control. Neural Plast 10:107-120
93. Gunawardena S, Goldstein LSB (2005) Polyglutamine diseases and transport problems. Arch Neurol 62:46-51
94. Gutekunst CA, Li SH, Yi H, Mulroy JS, Kuemmerle S, Jones R, Rye D, Ferrante RJ, Hersch SM, Li XJ (1999) Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology. J Neurosci 19:2522-2534
95. Haber SN, Calzavara R (2009) The cortico-basal ganglia integrative network: the role of the thalamus. Brain Res Bull 78:69-74
96. Hadzi TC, Hendricks AE, Latourelle JC, Lunetta KL, Cupples LA, Gillis T, Mysore JS, Gusella JF, MacDonald ME, Myers RH, Vonsattel JP (2012) Assessment of cortical and striatal involvement in 523 Huntington disease brains. Neurology 79:1708-1715
97. Halliday G (2004) Substantia nigra and locus coeruleus. In: Paxinos G, Mai JK (eds) The human nervous system, 2nd edn. Elsevier, San Diego, pp 449-463
98. Halliday GM, McRitchie DA, Macdonald V, Double KL, Trent RJ, Mccusker E (1998) Regional specificity of brain atrophy in Huntington's disease. Exp Neurol 154:663-672
99. Harper PS (1992) The epidemiology of Huntington's disease. Hum Genet 89:365-376
100. Harting JK, Huerta MF, Frankfurter AJ, Strominger NL, Royce GJ (1980) Ascending pathways from the monkey superior colliculus: an autoradiographic analysis. J Comp Neurol 192:853-882
101. Hassel B, Tessler S, Faull RL, Emson PC (2008) Glutamate uptake is reduced in prefrontal cortex in Huntington's disease. Neurochem Res 33:232-237
102. Hassler R (1982a) Architectonic organization of the thalamic nuclei. In: Schaltenbrand G, Bailey P (eds) Stereotaxy of the human brain. Thieme, Stuttgart/New York, pp 140-180
103. Hassler R (1982b) Stereotaxic surgery for psychiatric disorders. In: Schaltenbrand G, Bailey P (eds) Stereotaxy of the human brain. Thieme, Stuttgart/New York, pp 570-590
104. Heathfield KW (1973) Huntington's chorea: a centenary review. Postgrad Med J 49:32-45
105. Hedreen JC, Peyser CE, Folstein SE, Ross CA (1991) Neuronal loss in layers V and VI of cerebral cortex in Huntington's disease. Neurosci Lett 133:257-261
106. Heinsen H, Heinsen YL (1991) Serial thick, frozen, gallocyanin stained sections of human central nervous system. J Histotechnol 14:167-173
107. Heinsen H, Rüb U (1997) Quantitative investigations of neural circuits in Huntington's disease. J Neural Transm 104:1139-1140
108. Heinsen H, Bauer M, Ulmar G, Gangnus D, Jungkunz G (1992) The entorhinal region in Huntington's disease: a cytoarchitectonic and quantitative investigation in five cases. Clin Neuropathol 11:226
109. Heinsen H, Strik M, Bauer M, Luther K, Ulmar G, Gangnus D, Jungkunz G, Eisenmenger W, Götz M (1994) Cortical and striatal neurone number in Huntington's disease. Acta Neuropathol 88:320-333
110. Heinsen H, Rüb U, Gangnus D, Jungkunz G, Bauer M, Ulmar G, Bethke B, Schüler M, Böcker F, Eisenmenger W, Götz M, Strik M (1996) Nerve cell loss in the thalamic centromedianparafascicular complex in patients with Huntington's disease. Acta Neuropathol 91:161-168
111. Heinsen H, Rüb U, Bauer M, Ulmar G, Bethke B, Schüler M, Böcker F, Eisenmenger W, Götz M, Korr H, Schmitz C (1999) Nerve cell loss in the thalamic mediodorsal nucleus in Huntington's disease. Acta Neuropathol 97:613-622
112. Hennerici M, Homberg V, Lange HW (1985) Evoked potentials in patients with Huntington's disease and their offspring. II. Visual evoked potentials. Electroencephalogr Clin Neurophysiol 62:167-176
113. Herrero MT, Barcia C, Navarro JM (2002) Functional anatomy of thalamus and basal ganglia. Childs Nerv Syst 18:386-404
114. Hirai T, Jones EG (1989) A new parcellation of the human thalamus on the basis of histochemical staining. Brain Res Rev 14:1-34
115. Hoche F, Seidel K, Brunt ER, Auburger G, Schöls L, Bürk K, de Vos RA, den Dunnen W, Bechmann I, Egensperger R, Van Broeckhoven C, Gierga K, Deller T, Rüb U (2008) Involvement of the auditory brainstem system in spinocerebellar ataxia type 2 (SCA2), type 3 (SCA3) and type 7 (SCA7). Neuropathol Appl Neurobiol 34:479-491
116. Hodges A, Strand AD, Aragaki AK, Kuhn A, Sengstag T, Hughes G, Elliston LA, Hartog C, Goldstein DR, Thu D, Hollingsworth ZR, Collin F, Synek B, Holmans PA, Young AB, Wexler N, Delorenzi M, Kooperberg C, Augood SJ, Faull RLM, Olson JM, Jones L, Luthi-Carter R (2006) Regional and cellular gene expression changes in human Huntington's disease brain. Hum Mol Genet 15:965-977
117. Horn AK (2006) The reticular formation. Prog Brain Res 151:127-155
118. Horn AKE, Büttner-Ennever JA (1998) Premotor neurons for vertical eye movements in the rostral mesencephalon of monkey and human: Histologic identification by parvalbumin immunostaining. J Comp Neurol 392:413-427
119. Horn AKE, Büttner-Ennever JA, Wahle P, Reichenberger I (1994) Neurotransmitter profile of saccadic omnipause neurons in nucleus raphe interpositus. J Neurosci 14:2032-2046
120. Horn AKE, Büttner-Ennever JA, Suzuki A, Henn V (1995) Histological identification of premotor neurons for horizontal saccades in monkeys and man by parvalbumin immunostaining. J Comp Neurol 359:350-563
121. Horn AKE, Büttner U, Büttner-Ennever JA (1999) Brainstem and cerebellar structures for eye movement generation. Adv Otorhinolaryngol 55:1-25
122. Huerta MF, Krubitzer LA, Kaas JH (1986) Frontal eye field as defined by intracortical microstimulation in squirrel monkeys, owl monkeys, and macaque monkeys: I. Subcortical connections. J Comp Neurol 253:415-439
123. Hunt JR (1917) Progressive atrophy of the globus pallidus. Brain 40:58-148
124. Huntington G (1872) On chorea. Med Surg Reporter 26:317-321
125. Imarisio S, Carmichael J, Korolchuk V, Chen CW, Saiki S, Rose C, Krishna G, Davies JE, TtofiE, Underwood BR, Rubinsztein DC (2008) Huntington's disease: from pathology and genetics to potential therapies. Biochem J 412:191-209
126. Itzhaki RF, Wozniak MA, Appelt DM, Balin BJ (2004) Infiltration of the brain by pathogens causes Alzheimer's disease. Neurobiol Aging 25:619-627
127. Jelgersma G (1908) Über anatomische Befunde bei Paralyis agitans und bei chronischer Chorea. Neurol Centralblatt 27:995-996
128. Jellinger KA (2006) Alzheimer 100 - Highlights in the history o Alzheimer research. J Neural Transm 113:1603-1623
129. Jeste DV, Barban L, Parisi J (1984) Reduced Purkinje cell density in Huntington's disease. Exp Neurol 85:78-86
130. Jones EG (1985) The thalamus. Plenum Press, New York/London
131. Jones EG (2003) Two minds. Nature 421:19-20
132. Josiassen RC, Shagass C, Mancall EL, Roemer RA (1984) Auditory and visual evoked potentials in Huntington's disease. Electroencephalogr Clin Neurophysiol 57:113-118
133. Jucker M, Walker LC (2011) Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders. Ann Neurol 70:532-540
134. Kato S, Hirano A, Umahara T, Llena JF, Herz F, Ohama E (1992) Ultrastructural and immunohistochemical studies on ballooned cortical neurons in Creutzfeldt-Jakob disease: expression of αB-crystallin, ubiquitin and stress-response protein 27. Acta Neuropathol 84:443-448
135. Kennard C, Lueck CJ (1989) Oculomotor abnormalities in diseases of the basal ganglia. Rev Neurol 145:587-595
136. Kiesselbach G (1914) Anatomischer Befund eines Falles von Huntingtonscher Chorea. Monatsschr Psychiat Neurol 35:525-543
137. Kirkwood SC, Siemers E, Hodes ME, Conneally PM, Christian JC, Foroud T (2000) Subtle changes among presymptomatic carriers of the Huntington's disease gene. J Neurol Neurosurg Psychiatry 69:773-779
138. Knikou M (2008) The H-reflex as a probe: pathways and pitfalls. J Neurosci Methods 171:1-12
139. Koeppen AH (1989) The nucleus pontis centralis caudalis in Huntington's disease. J Neurol Sci 91:129-141
140. Koller WC, Trimble J (1985) The gait abnormality of Huntington's disease. Neurology 35:1450-1454
141. Kremer B, Weber B, Hayden MR (1992) New insights into the clinical features, pathogenesis and molecular genetics of Huntington disease. Brain Pathol 2:321-335
142. Kuemmerle S, Gutekunst CA, Klein AM, Li XJ, Li SH, Beal MF, Hersch SM, Ferrante RJ (1999) Huntington aggregates may not predict neuronal death in Huntington's disease. Ann Neurol 46:842-849
143. Künzle H, Akert K (1977) Efferent connections of cortical area 8 (frontal eye field) in Macaca fascicularis. A reinvestigation using the autoradiographic technique. J Comp Neurol 173:147-164
144. Kuusisto E, Salminen A, Alafuzoff I (2001) Ubiquitin-binding protein p62 is present in neuronal and glial inclusions in human tauopathies and synucleinopathies. Neuroreport 12:2085-2090
145. Kuusisto E, Kauppinen T, Alafuzoff I (2008) Use of p62/SQSTM1 antibodies for neuropathological diagnosis. Neuropathol Appl Neurobiol 34:169-180
146. Labbadia J, Morimoto RI (2013) Huntington's disease: underlying molecular mechanisms and emerging concepts. Trends Biochem Sci 38:378-385
147. Lace GL, Wharton SB, Ince PG (2007) A brief history of tau: the evolving view of the microtubuleassociated protein tau in neurodegenerative diseases. Clin Neuropathol 26:43-58
148. Landwehrmeyer GB, McNeil SM, Dure LS, Ge P, Aizawa H, Huang Q, Ambrose CM, Duyao MP, Bird ED, Bonilla E (1995) Huntington's disease gene: regional and cellular expression in brain of normal and affected individuals. Ann Neurol 37:218-223
149. Lange HW (1981) Quantitative changes of telencephalon, diencephalon, and mesencephalon in Huntington's chorea, postencephalitic, and idiopathic Parkinsonism. Verh Anat Ges 73:923-925
150. Lange HW, Aulich A (1986) Die Hirnatrophie bei der Huntingtonschen Krankheit. In: Oepen H (ed) Die Huntingtonsche Krankheit. Hippokrates, Stuttgart, pp 25-41
151. Lange H, Thorner G, Hopf A, Schröder KF (1976) Morphometric studies of the neuropathological changes in choreatic diseases. J Neurol Sci 28:401-425
152. Lanska DJ (2000) George Huntington (1850-1916) and hereditary chorea. J Hist Neurosci 9:76-89
153. Lanska DJ (2010) The history of movement disorders. In: Finger S, Boller F, Tyler KL (eds) Handbook of clinical neurology, vol 95. Elsevier, Amsterdam, pp 501-546
154. Lasker AG, Zee DS (1997) Ocular motor abnormalities in Huntington's disease. Vision Res 37:3639-3645
155. Lasker AG, Zee DS, Hain TC, Folstein SE, Singer HS (1987) Saccades in Huntington's disease: initiation defects and distractibility. Neurology 37:364-370
156. Lasker AG, Zee DS, Hain TC, Folstein SE, Singer HS (1988) Saccades in Huntington's disease: slowing and dysmetria. Neurology 38:427-431
157. Lastres-Becker I, Rüb U, Auburger G (2008) Spinocerebellar ataxia 2 (SCA2). Cerebellum 7:115-124
158. Leak RK (2014) Heat shock proteins in neurodegenerative disorders and aging. J Cell Commun Signal 8:293-310
159. Leigh RJ, Kennard C (2004) Using saccades as a research tool in the clinical neurosciences. Brain 127:460-477
160. Leigh RJ, Zee DS (2006) The neurology of eye movements, 4th edn. Oxford University Press, Oxford
161. Leigh RJ, Newman SA, Folstein SE, Lasker AG, Jensen BA (1983) Abnormal ocular motor control in Huntington's disease. Neurology 33:1268-1275
162. Leigh RJ, Parhad IM, Clark AW, Buettner-Ennever JA, Folstein SE (1985) Brainstem findings in Huntington's disease. Possible mechanisms for slow vertical saccades. J Neurol Sci 71:247-256
163. Leopold HC, Doerr M, Oepen G, Thoden U (1982) The effect of cervical and vestibular reflexes on eye movements in Huntington's chorea. Arch Psychiatr Nervenkr 231:227-234
164. Lewy FH (1923) Die Histopathologie der choreatischen Erkrankungen. Zschr ges Neurol Psychiatr 85:622-658
165. Li JY, Conforti L (2013) Axonopathy in Huntington's disease. Exp Neurol 246:62-71
166. Li XJ, Li S (2011) Proteasomal dysfunction in aging and Huntington disease. Neurobiol Dis 43:4-8
167. Lin YS, Chen CM, Soong BW, Wu YR, Chen HM, Yeh WY, Wu DR, Lin YJ, Poon PW, Cheng ML, Wang CH, Chern Y (2011) Dysregulated brain creatine kinase is associated with hearing impairment in mouse models of Huntington disease. J Clin Invest 121:1519-1523
168. Lund JC (1860) Chorea Sti Viti i Sætersdalen. Uddrag af Distriktslæge J. C. Lunds Medicinalberetning for 1860. Beretning om Sundhedstilstanden (Norway): 137-138
169. Lyon IW (1863) Chronic hereditary chorea. Am Med Times 7:289-290
170. Maat-Schieman ML, Dorsman JC, Smoor MA, Siesling S, van Duinen SG, Verschuuren JJ, den Dunnen JT, van Ommen GJ, Roos RA (1999) Distribution of inclusions in neuronal nuclei and dystrophic neurites in Huntington disease brain. J Neuropathol Exp Neurol 58:129-137
171. Maat-Schieman M, Roos R, Losekoot M, Dorsman J, Welling-Graafland C, Hegeman-Kleinn I, Broeyer F, Breuning M, van Duinen S (2007) Neuronal intranuclear and neuropil inclusions for pathological assessment of Huntington's disease. Brain Pathol 17:31-37
172. MacDonald V, Halliday G (2002) Pyramidal cell loss in motor cortices in Huntington's disease. Neurobiol Dis 10:378-386
173. MacDonald V, Halliday GM, Trent RJ, McCusker EA (1997) Significant loss of pyramidal neurons in the angular gyrus of patients with Huntington's disease. Neuropathol Appl Neurobiol 23:492-495
174. Mann DM, Oliver R, Snowden JS (1993) The topographic distribution of brain atrophy in Huntington's disease and progressive supranuclear palsy. Acta Neuropathol 85:553-559
175. Margolis RL, Ross CA (2003) Diagnosis of Huntington disease. Clin Chem 49:1726-1732
176. Markowitsch HJ (1982) Thalamic mediodorsal nucleus and memory: a critical evaluation of studies in animals and man. Neurosci Biobehav Rev 6:351-380
177. May PJ (2006) The mammalian superior colliculus: laminar structure and connections. Prog Brain Res 151:321-378
178. McCaughey WTE (1961) The pathologic spectrum of Huntington's chorea. J Nerv Ment Dis 133:91-103
179. McFarland NR, Haber SN (2002) Thalamic relay nuclei of the basal ganglia form both reciprocal and nonreciprocal cortical connections, linking multiple frontal cortical areas. J Neurosci 22:117-132
180. McLardy T (1948) Projection of the centromedian nucleus of the human thalamus. Brain 71:290-303
181. McLeod JG (1969) H-reflex studies in patients with cerebellar disorders. J Neurol Neurosurg Psychiatry 32:21-27
182. Mesulam MM (1998) From sensation to cognition. Brain 121:1013-1052
183. Meyer A, Beck F, McLardy T (1947) Prefrontal leucotomy: a neuroanatomical report. Brain 70:18-49
184. Millecamps S, Julien JP (2013) Axonal transport deficits and neurodegenerative diseases. Nat Rev Neurosci 14:161-176
185. Mink JW (1996) The basal ganglia: Focused selection and inhibition of competing motor programs. Prog Neurobiol 50:381-425
186. Misiaszek JE (2003) The H-reflex as a tool in neurophysiology: its limitations and uses in understanding nervous system function. Muscle Nerve 28:144-160
187. Modregger J, DiProspero NA, Charles V, Tagle DA, Plomann M (2002) PACSIN 1 interacts with huntingtin and is absent from synaptic varicosities in presymptomatic Huntington's disease brains. Hum Mol Genet 11:2547-2558
188. Montoya A, Price BH, Menear M, Lepage M (2006) Brain imaging and cognitive dysfunctions in Huntington's disease. J Psychiatry Neurosci 31:21-29
189. Moore JK, Linthicum FH (2004) Auditory system. In: Paxinos G, Maik JK (eds) The human nervous system, 2nd edn. Elsevier, San Diego, pp 1241-1279
190. Morecraft RJ, Geula C, Mesulam MM (1992) Cytoarchitecture and neural afferents of orbitofrontal cortex in the brain of the monkey. J Comp Neurol 323:341-358
191. Morel A, Magnin M, Jeanmonod D (1997) Multiarchitectonic and stereotactic atlas of the human thalamus. J Comp Neurol 387:588-630
192. Myers RH (2004) Huntington's disease genetics. NeuroRx 1:255-262
193. Myers RH, Vonsattel JP, Stevens TJ, Cupples LA, Richardson EP, Martin JB, Bird ED (1988) Clinical and neuropathologic assessment of severity in Huntington's disease. Neurology 38:341-347
194. Myers RH, Vonsattel JP, Paskevich PA, Kiely DK, Stevens TJ, Cupples LA, Richardson EPJ, Bird ED (1991) Decreased neuronal and increased oligodendroglial densities in Huntington's disease caudate nucleus. J Neuropathol Exp Neurol 50:729-742
195. Nakano K, Kayahara T, Tsutsumi T, Ushiro H (2000) Neural circuits and functional organization of the striatum. J Neurol 247(Suppl 5):V1-V5
196. Neustaedter M (1933) Concerning the striatal localization in chronic progressive chorea. With a report of three cases, two of the Huntington type in siblings and one senile arteriosclerotic, with necropsies. J Nerv Ment Dis 78:470-491
197. Nopoulos PC, Aylward EH, Ross CA, Johnson HJ, Magnotta VA, Juhl AR, Pierson RK, Mills J, Langbehn DR, Paulsen JS (2010) Cerebral cortex structure in prodromal Huntington disease. Neurobiol Dis 40:544-554
198. Norrby E (2011) Prions and protein-folding diseases. J Intern Med 270:1-14
199. Oepen G, Hillesheimer W (1981) Qualitative H-reflex testing in Huntington's disease. Arch Psychiatr Nervenkr 230:221-226
200. Oepen G, Ostertag C (1981) Diagnostic value of CT in patients with Huntington's chorea and their offspring. J Neurol 225:189-196
201. Oepen G, Clarenbach P, Thoden U (1981) Disturbance of eye movements in Huntington's chorea. Arch Psychiatr Nervenkr 229:205-213
202. Oepen G, Mohr U, Willmes K, Thoden U (1985) Huntington's disease: visuomotor disturbance in patients and offspring. J Neurol Neurosurg Psychiatry 48:426-433
203. Oliveira JMA (2010) Nature and cause of mitochondrial dysfunction in Huntington's disease: focusing on huntingtin and the striatum. J Neurochem 114:1-12
204. Oorschot DE (1994) Are you using neuronal densities, synaptic densities or neurochemical densities as your definitive data? There is a better way to go. Prog Neurobiol 44:233-247
205. Ortega Z, Díaz-Hernández M, Lucas JJ (2007) Is the ubiquitin-proteasome system impaired in Huntington's disease? Cell Mol Life Sci 64:2245-2257
206. Oyanagi K, Takeda S, Takahashi H, Ohama E, Ikuta F (1989) A quantitative investigation of the substantia nigra in Huntington's disease. Ann Neurol 26:13-19
207. Pandey M, Mohanakumar KP, Usha R (2010) Mitochondrial functional alterations in relation to pathophysiology of Huntington's disease. J Bioenerg Biomembr 42:217-226
208. Parent A (1990) Extrinsic connections of the basal ganglia. Trends Neurosci 13:254-258
209. Parent A, Hazrati LN (1995) Functional anatomy of the basal ganglia. 1. The cortico-basal gangliathalamo-cortical loop. Brain Res Rev 20:91-127
210. Pattison LR, Kotter MR, Fraga D, Bonelli RM (2006) Apoptotic cascades as possible targets for inhibiting cell death in Huntington's disease. J Neurol 253:1137-1142
211. Paul S (2008) Dysfunction of the ubiquitin-proteasome system in multiple disease conditions: therapeutic approaches. Bioessays 3:1172-1184
212. Paulus W, Jellinger K (1991) The neuropathologic basis of different clinical subgroups of Parkinson's disease. J Neuropathol Exp Neurol 50:743-755
213. Peltsch A, Hoffman A, Armstrong I, Pari G, Munoz DP (2008) Saccadic impairments in Huntington's disease. Exp Brain Res 186:457-469
214. Penney JB Jr, Vonsattel JP, MacDonald ME, Gusella JF, Myers RH (1997) CAG repeat number governs the development rate of pathology in Huntington's disease. Ann Neurol 41:689-692
215. Petersen A, Gil J, Maat-Schieman ML, Bjorkqvist M, Tanila H, Araujo IM, Smith R, Popovic N, Wierup N, Norlen P, Li JY, Ross RA, Sundler F, Mulder H, Brundin P (2005) Orexin loss in Huntington's disease. Hum Mol Genet 14:39-47
216. Pfeiffer JAF (1913) A contribution to the pathology of chronic progressive chorea. Brain 35:276-292
217. Pillon B, Deweer B, Agid Y, Dubois B (1993) Explicit memory in Alzheimer's, Huntington's, and Parkinson's diseases. Arch Neurol 50:374-379
218. Rapoport SI (1990) Integrated phylogeny of the primate brain, with special reference to humans and their diseases. Brain Res Rev 15:267-294
219. Renner M, Melki R (2014) Protein aggregation and prionopathies. Pathol Biol 62:162-168
220. Richardson EP Jr (1990) Third Dorothy S. Russell memorial lecture. Huntington's disease: some recent neuropathological studies. Neuropathol Appl Neurobiol 16:451-460
221. Riess O, Rüb U, Pastore A, Bauer P, Schöls L (2008) SCA3: neurological features, pathogenesis and animal models. Cerebellum 7:125-137
222. Robinson FR, Fuchs AF (2001) The role of the cerebellum in voluntary eye movements. Annu Rev Neurosci 24:981-1004
223. Rodda RA (1981) Cerebellar atrophy in Huntington's disease. J Neurol Sci 50:147-157
224. Roos RA, Pruyt JF, de Vries J, Bots GT (1985) Neuronal distribution in the putamen in Huntington's disease. J Neurol Neurosurg Psychiatry 48:422-425
225. Rosas HD, Liu AK, Hersch S, Glessner M, Ferrante RJ, Salat DH, van der Kouwe A, Jenkins BG, Dale AM, Fischl B (2002) Regional and progressive thinning of the cortical ribbon in Huntington's disease. Neurology 58:695-701
226. Rosas HD, Koroshetz WJ, Chen YI, Skeuse C, Vangel M, Cudkowicz ME, Kaplan K (2003) Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis. Neurology 60:1615-1620
227. Ross CA, Tabrizi SJ (2011) Huntington's disease: from molecular pathogenesis to clinical treatment. Lancet Neurol 10:83-98
228. Rüb U, Del Tredici K, Schultz C, Büttner-Ennever JA, Braak H (2001) The premotor region essential for rapid vertical eye movements shows early involvement in Alzheimer's disease-related cytoskeletal pathology. Vision Res 41:2149-2156
229. Rüb U, Brunt ER, Gierga K, Schultz C, Paulson H, de Vos RA, Braak H (2003a) The nucleus raphe interpositus in spinocerebellar ataxia type 3 (Machado-Joseph disease). J Chem Neuroanat 25:115-127
230. Rüb U et al (2003b) Thalamic involvement in a spinocerebellar ataxia type 2 (SCA2) and a spinocerebellar ataxia type 3 (SCA3) patient, and its clinical relevance. Brain 126:2257-2272
231. Rüb U, Brunt ER, de Vos RA, Del Turco D, Del Tredici K, Gierga K, Schultz C, Ghebremedhin E, Bürk K, Auburger G, Braak H (2004a) Degeneration of the central vestibular system in spinocerebellar ataxia type 3 (SCA3) patients and its possible clinical significance. Neuropathol Appl Neurobiol 30:402-414
232. Rüb U, Bürk K, Schöls L, Brunt ER, de Vos RA, Diaz GO, Gierga K, Ghebremedhin E, Schultz C, Del Turco D, Mittelbronn M, Auburger G, Deller T, Braak H (2004b) Damage to the reticulotegmental nucleus of the pons in spinocerebellar ataxia type 1, 2, and 3. Neurology 63:1258-1263
233. Rüb U, Gierga K, Brunt ER, de Vos RA, Bauer M, Schöls L, Bürk K, Auburger G, Bohl J, Schultz C, Vuksic M, Burbach GJ, Braak H, Deller T (2005) Spinocerebellar ataxias types 2 and 3: degeneration of the precerebellar nuclei isolates the three phylogenetically defined regions of the cerebellum. J Neural Transm 112:1523-1545
234. Rüb U, Brunt ER, Deller T (2008a) New insights into the pathoanatomy of spinocerebellar ataxia type 3 (Machado-Joseph disease). Curr Opin Neurol 21:111-116
235. Rüb U, Jen JC, Braak H, Deller T (2008b) Functional neuroanatomy of the human premotor oculomotor brainstem nuclei: insights from postmortem and advanced in vivo imaging studies. Exp Brain Res 187:167-180
236. Rüb U, Heinsen H, Brunt ER, Landwehrmeyer B, den Dunnen WF, Gierga K, Deller T (2009) The human premotor oculomotor brainstem system - can it help to understand oculomotor symptoms in Huntington's disease? Neuropathol Appl Neurobiol 35:4-15
237. Rüb U, Hoche F, Brunt ER, Heinsen H, Seidel K, Del Turco D, Paulson HL, Bohl J, von Gall C, Vonsattel JP, Korf HW, den Dunnen WF (2013a) Degeneration of the cerebellum in Huntington's disease (HD): possible relevance for the clinical picture and potential gateway to pathological mechanisms of the disease process. Brain Pathol 23:165-177
238. Rüb U, Schöls L, Paulson H, Auburger G, Kermer P, Jen JC, Seidel K, Korf HW, Deller T (2013b) Clinical features, neurogenetics and neuropathology of the polyglutamine spinocerebellar ataxias type 1, 2, 3, 6 and 7. Prog Neurobiol 104:38-66
239. Rüb U, Hentschel M, Stratmann K, Brunt E, Heinsen H, Seidel K, Bouzrou M, Auburger G, Paulson H, Vonsattel JP, Lange H, Korf HW, den Dunnen W (2014a) Huntington's disease (HD): degeneration of select nuclei, widespread occurrence of neuronal nuclear and axonal inclusions in the brainstem. Brain Pathol 24:247-260
240. Rüb U, Seidel K, Vonsattel JP, Lange HW, Eisenmenger W, Götz, M, Del Turco, D, Bouzrou M, Korf HW, Heinsen H (2014b) Huntington's disease (HD): neurodegeneration of Brodmann's primary visual area 17 (BA17). Brain Pathol [Epub ahead of print]
241. Sadikot AF, Rymar VV (2009) The primate centromedian-parafascicular complex: anatomical organization with a note on neuromodulation. Brain Res Bull 78:122-130
242. Sadikot AF, Parent A, Franqois C (1992a) The centre median and parafascicular thalamic nuclei project respectively to the sensorimotor and associative-limbic striatal territories in the squirrel monkey. Brain Res 510:161-165
243. Sadikot AF, Parent A, Francois C (1992b) Efferent connections of the centromedian and parafascicular thalamic nuclei in the squirrel monkey: a PHA-L study of subcortical projections. J Comp Neurol 315:137-159
244. Salmon DP, Kwo on Yuen, PF, Heindel WC, Butters N, Thal LJ (1989) Differentiation of Alzheimer's disease and Huntington's disease with the Dementia Rating Scale. Arch Neurol 46:1204-1208
245. Sapp E, Penney J, Young A, Aronin N, Vonsattel JP, Difiglia M (1999) Axonal transport of N-terminal huntingtin suggests early pathology of corticostriatal projections in Huntington disease. J Neuropathol Exp Neurol 58:165-173
246. Schapira AH, Olanow CW, Greenamyre JT, Bezard E (2014) Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives. Lancet 384:545-555
247. Scherzed W, Brunt ER, Heinsen H, de Vos RA, Seidel K, Bürk K, Schöls L, Auburger G, Del Turco D, Deller T, Korf HW, den Dunnen WF, Rüb U (2012) Pathoanatomy of cerebellar degeneration in spinocerebellar ataxia type 2 (SCA2) and type 3 (SCA3). Cerebellum 11:749-760
248. Schmitz C, Hof PR (2005) Design-based stereology in neuroscience. Neuroscience 130:813-831
249. Schroeder K (1931) Zur Klinik und Pathologie der Huntingtonschen Krankheit. J Psychol Neurol 43:183-201
250. Schulte J, Littleton JT (2011) The biological function of the Huntingtin protein and its relevance to Huntington's Disease pathology. Curr Trends Neurol 5:65-78
251. Seibenhener ML, Babu JR, Geetha T, Wong HC, Krishna NR, Wooten MW (2004) Sequestosome 1/p62 is a polyubiquitin chain binding protein involved in ubiquitin proteasome degradation. Mol Cell Biol 24:8055-8068
252. Seidel K, Brunt ER, de Vos RA, Dijk F, van der Want HJ, Rüb U, Den Dunnen WF (2009) The p62 antibody reveals various cytoplasmic protein aggregates in spinocerebellar ataxia type 6. Clin Neuropathol 28:344-349
253. Seidel K, Den Dunnen WF, Schultz C, Paulson H, Frank S, de Vos RA, Brunt ER, Deller T, Kampinga HH, Rüb U (2010) Axonal inclusions in spinocerebellar ataxia type 3. Acta Neuropathol 120:449-460
254. Seidel K, Siswanto S, Brunt ER, den Dunnen W, Korf HW, Rüb U (2012) Brain pathology of spinocerebellar ataxias. Acta Neuropathol 124:1-21
255. Seidel K, Mahlke J, Siswanto S, Krüger R, Heinsen H, Auburger G, Bouzrou M, Grinberg LT, Wicht H, Korf HW, den Dunnen W, Rüb U (2015) The brainstem pathologies of Parkinson's disease and dementia with lewy bodies. Brain Pathol 25:121-135
256. Selemon LD, Rajkowska G, Goldman-Rakic PS (2004) Evidence for progression in frontal cortical pathology in late-stage Huntington's disease. J Comp Neurol 468:190-204
257. Shaw G, Osborn M, Weber K (1981) An immunofluorescence microscopical study of the neurofilament triplet proteins, vimentin and glial fibrillary acidic protein within the adult rat brain. Eur J Cell Biol 26:68-82
258. Sheperd GM (2013) Corticostriatal connectivity and its role in disease. Nat Rev Neurosci 14:278-291
259. Shoulson I, Young AB (2011) Milestones in huntington disease. Mov Disord 26:1127-1133
260. Sieradzan KA, Mann DM (2001) The selective vulnerability of nerve cells in Huntington's disease. Neuropathol Appl Neurobiol 27:1-21
261. Sieradzan KA, Mechan AO, Jones L, Wanker EE, Nukina N, Mann DM (1999) Huntington's disease intranuclear inclusions contain truncated, ubiquitinated huntingtin protein. Exp Neurol 156:92-99
262. Smith R, Klein P, Koc-Schmitz Y, Waldvogel HJ, Faull RL, Brundin P, Plomann M, Li JY (2007) Loss of SNAP-25 and rabphilin 3a in sensory-motor cortex in Huntington's disease. J Neurochem 103:115-123
263. Sommer MA, Wurtz RH (2004) What the brain stem tells the frontal cortex. I. Oculomotor signals sent from superior colliculus to frontal eye field via mediodorsal thalamus. J Neurophysiol 91:1381-13402
264. Sotrel A, Paskevich PA, Kiely DK, Bird ED, Williams RS, Myers RH (1991) Morphometric analysis of the prefrontal cortex in Huntington's disease. Neurology 41:1117-1121
265. Sotrel A, Williams RS, Kaufmann WE, Myers RH (1993) Evidence for neuronal degeneration and dendritic plasticity in cortical pyramidal neurons of Huntington's disease: a quantitative Golgi study. Neurology 43:2088-2096
266. Spielmeyer W (1926) Die anatomische Krankheitsforschung am Beispiel einer Huntingtonschen Chorea mit Wilsonschem Symptomenbild. Zschr ges Neurol Psychiatr 101:701-728
267. Stanton GB, Goldberg ME, Bruce CJ (1988) Frontal eye field efferents in the macaque monkey. I Subcortical pathways and topography of striatal and thalamic terminal fields. J Comp Neurol 271:473-492
268. Starr A (1967) A disorder of rapid eye movements in Huntington's chorea. Brain 90:545-564
269. Stier E (1903) Zur pathologischen Anatomie der Huntingtonschen Chorea. Arch f Psych 37:62-86
270. Stover NP, Watts RL (2001) Corticobasal degeneration. Sem Neurol 21:49-58
271. Tabrizi SJ, Scahill RI, Durr A, Roos RA, Leavitt BR, Jones R, Landwehrmeyer GB, Fox NC, Johnson H, Hicks SL, Kennard C, Craufurd D, Frost C, Langbehn DR, Reilmann R, Stout JC (2011) Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis. Lancet Neurol 10:31-42
272. Tanner CM, Goldman SM (1994) Epidemiology of movement disorders. Curr Opin Neurol 7:340-345
273. Terplan K (1924) Zur pathologischen Anatomie der chonischen progressiven Chorea. Arch Path Anat 252:146-176
274. The Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72:971-983
275. Thu DC, Oorschot DE, Tippett LJ, Nana AL, Hogg VM, Synek BJ, Luthi-Carter R, Waldvogel HJ, Faull RL (2010) Cell loss in the motor and cingulate cortex correlates with symptomatology in Huntington's disease. Brain 133:1094-1110
276. Tian JR, Zee DS, Lasker AG, Folstein SE (1991) Saccades in Huntington's disease: predictive tracking and interaction between release of fixation and initiation of saccades. Neurology 41:875-881
277. Trottier Y, Lutz Y, Stevanin G, Imbert DD, Cancel G, Saudou F, Weber C, David G, Tora L, Agid Y, Brice A, Mandel JL (1995) Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias. Nature 378:403-406
278. U.S.-Venezuela Collaborative Research Project, Wexler NS (2004) Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. Proc Natl Acad Sci U S A 101:3498-3503
279. Valera AG, Diaz-Hernandez M, Hernandez F, Ortega Z, Lucas JJ (2005) The ubiquitin-proteasome system in Huntington's disease. Neuroscientist 11:583-594
280. van Wamelen DJ, Aziz NA, Roos RA, Swaab DF (2014) Hypothalamic alterations in Huntington's disease patients: comparison with genetic rodent models. J Neuroendocrinol 26:761-775
281. Vogt C, Vogt O (1920) Zur Lehre der Erkrankungen des striären Systems. J Psychol Neurol 25(Suppl 3):631-846
282. Vogt C, Vogt O (1942) Morphologische Gestaltungen unter normalen und pathogenen Bedingungen. Ein hirnanatomischer Beitrag zu ihrer Kenntnis. J Psychol Neurol 50:161-524
283. von Economo C, Koskinas GN (1925) Die Cytoarchitekonik der Hirnrinde des erwachsenen Menschen. Julius Springer, Wien Berlin
284. Vonsattel JP (2008) Huntington disease models and human neuropathology: similarities and differences. Acta Neuropathol 115:55-69
285. Vonsattel JP, DiFiglia M (1998) Huntington disease. J Neuropathol Exp Neurol 57:369-384
286. Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP Jr (1985) Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 44:559-577
287. Voogd J (2003) The human cerebellum. J Chem Neuroanat 26:243-252
288. Voogd J, Barmack NH (2006) Oculomotor cerebellum. Prog Brain Res 151:231-268
289. Voogd J, Feirabend HKP, Schoen JHR (1990) Cerebellum and precerebellar nuclei. In: Paxinos G (ed) The human central nervous system. Academic Press, San Diego, pp 321-386
290. Voogd J, Schraa-Tam CKL, van der Geest JN, De Zeeuw CI (2010) Visuomotor cerebellum in human and nonhuman primates. Cerebellum 11:392-410
291. Walker AE (1982) Normal and pathological physiology of the thalamus. In: Schaltenbrand G, Walker AE (eds) Stereotaxy of the human brain. Anatomical, physiological and clinical applications. Thieme, Stuttgart/New York, pp 181-217
292. Walker FO (2007a) Huntington's disease. Semin Neurol 27:143-150
293. Walker FO (2007b) Huntington's disease. Lancet 369:218-228
294. Waters CO (1842) Letter on chorea. In: Dunglison R (ed) The practice of medicine, vol 2. Lea and Blanchard, Philadelphia, pp 312-313
295. West MJ, Gundersen HJ (1990) Unbiased stereological estimation of the number of neurons in the human hippocampus. J Comp Neurol 296:1-22
296. Whitney ER, Kemper TL, Rosene DL, Bauman ML, Blatt GJ (2008) Calbindin-D28k is a more reliable marker of human Purkinje cells than standard Nissl stains: a stereological experiment. J Neurosci Methods 168:42-47
297. Winograd-Gurvich CT, Georgiou-Karistianis N, Evans A, Millist L, Bradshaw JL, Churchyard A, Chiu E, White OB (2003) Hypometric primary saccades and increased variability in visuallyguided saccades in Huntington's disease. Neuropsychologia 41:1683-1692
298. Wooten MW, Hu X, Babu JR, Seibenhener ML, Geetha T, Paine MG, Wooten MC (2006) Signaling, polyubiquitination, trafficking, and inclusions: sequestosome 1/p62's role in neurodegenerative disease. J Biomed Biotechnol 2006:1-12. Article ID 62079
299. Yanagisawa N (1992) The spectrum of motor disorders in Huntington's disease. Clin Neurol Neurosurg 94(Suppl):182-184
300. Zilles K (1990) Cortex. In: Paxinos G (ed) The human nervous system. Academic Press, San Diego, pp 757-780